Starter package
Latest from The Phage
Fresh stories, protocols, and interviews from the phage world.
Research digest
AI-Designed Phage Genomes Show Promise Against Antibiotic Resistance
Researchers from Arc Institute and collaborators have demonstrated that AI foundation models—Evo 1 and Evo 2—can design fully functional phage genomes, offering…
PHAGE THERAPY
The Promise of Personalized Phage Therapy
Imagine being ill with an infection that no antibiotic can cure. For many people around the world, this is a frightening reality…
PHAGE THERAPY
Vésale Bioscience Rebrands as Inteliphage, Signaling Shift Toward Clinical Application of Phage Therapy
Belgian biotech company Vésale Bioscience has officially rebranded as Inteliphage, marking a strategic evolution in its mission and scope. The company, known…
Know your phage
Enveloped vs Non-Enveloped Viruses: Key Differences, Structure & Examples
Understanding the difference between enveloped and non-enveloped viruses is key to virology, infection control, and antiviral development. This guide dives deep into…
PHAGE RESISTANCE
Nebulized phage therapy treats cystic fibrosis cases
The incidence of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) is alarming. And so are the MDR(Multi-drug resistant) cases and PDR(PAN…
AMR
Phage therapy as “One-Health” approach in aquaculture
The overuse of antibiotics has led to antimicrobial resistance, now with scientific society looking out for potential alternatives not only for human…
